Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

EM-12

Copy Product Info
🥰Excellent
Catalog No. T41362Cas No. 26581-81-7
Alias Phthalimidinoglutarimide, 2-(2,6-Dioxopiperidin-3-yl)phthalimidine

2-(2,6-Dioxopiperidin-3-yl)phthalimidine (EM-12 (2-(2,6-Dioxopiperidin-3-yl)phthalimidine)) is a teratogenic Thalidomide analogue that is more active and significantly more stable against hydrolysis than Thalidomide, enhancing 1,2-dimethylhydrazine-induced rat colon adenocarcinomas [1] [2].

EM-12

EM-12

Copy Product Info
🥰Excellent
Purity: 99.34%
Catalog No. T41362Alias Phthalimidinoglutarimide, 2-(2,6-Dioxopiperidin-3-yl)phthalimidineCas No. 26581-81-7
2-(2,6-Dioxopiperidin-3-yl)phthalimidine (EM-12 (2-(2,6-Dioxopiperidin-3-yl)phthalimidine)) is a teratogenic Thalidomide analogue that is more active and significantly more stable against hydrolysis than Thalidomide, enhancing 1,2-dimethylhydrazine-induced rat colon adenocarcinomas [1] [2].
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
10 mg$40In StockIn Stock
25 mg$81In StockIn Stock
50 mg$118In StockIn Stock
100 mg$179In StockIn Stock
1 mL x 10 mM (in DMSO)$29In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.34%
Appearance:Solid
Color:Blue
Contact us for more batch information

Resource Download

Product Introduction

EM-12 AI Summary
EM-12 displays significant bioactivity and pharmacokinetic properties across a range of assays. Notably, it inhibits angiogenesis in a rat aortic ring model, exhibiting a consistent 30% inhibition of microvessel outgrowth at concentrations of 100 uM and 200 uM in Endothelial Basal Medium with Dimethylsulfoxide. The compound demonstrates favorable distribution characteristics, with a logD value of 0.498 at 1 mg/ml under pH 7.4 conditions and good permeability in human Caco-2 cells, with an apparent permeability of 22.2 x 10^-6 cm/s and an efflux ratio close to 1 (0.99). It also has high kinetic solubility in PBS at 200 uM, with solubility reaching 451,000 nM after 30 minutes of incubation. In terms of metabolic stability, EM-12 exhibits a half-life of 1.983 hours in human plasma and greater than 3.1 hours in human liver microsomes in the presence of NADPH. The compound shows relatively low intrinsic clearance rates in both human liver microsomes and hepatocytes, indicating higher metabolic stability. Within human MOLT-4 cells, EM-12 achieves complete drug accumulation and maintains a high intracellular bioavailability of 220.0%. The compound also modulates CRBN/IKZF1, demonstrating Protac activity with a DC50 value of 192.7 nM and 69.0% maximum degradation of IKZF1 after 24 hours. Overall, EM-12 offers substantial therapeutic potential due to its robust bioactivity, favorable distribution, and metabolic profiles..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
2-(2,6-Dioxopiperidin-3-yl)phthalimidine (EM-12 (2-(2,6-Dioxopiperidin-3-yl)phthalimidine)) is a teratogenic Thalidomide analogue that is more active and significantly more stable against hydrolysis than Thalidomide, enhancing 1,2-dimethylhydrazine-induced rat colon adenocarcinomas [1] [2].
SynonymsPhthalimidinoglutarimide, 2-(2,6-Dioxopiperidin-3-yl)phthalimidine
Chemical Properties
Molecular Weight244.25
FormulaC13H12N2O3
Cas No.26581-81-7
SmilesO=C1N(CC=2C1=CC=CC2)C3C(=O)NC(=O)CC3
Relative Density.1.2650 g/cm3 (Estimated)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 11 mg/mL (45.04 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM4.0942 mL20.4708 mL40.9417 mL204.7083 mL
5 mM0.8188 mL4.0942 mL8.1883 mL40.9417 mL
10 mM0.4094 mL2.0471 mL4.0942 mL20.4708 mL
20 mM0.2047 mL1.0235 mL2.0471 mL10.2354 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy EM-12 | purchase EM-12 | EM-12 cost | order EM-12 | EM-12 chemical structure | EM-12 formula | EM-12 molecular weight